Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
2.060
+0.030 (1.48%)
At close: Apr 28, 2026, 4:00 PM EDT
1.990
-0.070 (-3.40%)
After-hours: Apr 28, 2026, 7:01 PM EDT
Acurx Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -7.97 | -14.1 | -14.58 | -12.09 | -12.75 | |
| Stock-Based Compensation | 1.57 | 3.44 | 3.77 | 3.3 | 6.07 | |
| Other Operating Activities | - | - | - | - | 1.52 | |
| Change in Accounts Payable | -0.41 | 0.2 | 0.98 | 1.22 | 0.39 | |
| Change in Other Net Operating Assets | 0.02 | 0.08 | 0.03 | 0.03 | -0.25 | |
| Operating Cash Flow | -6.79 | -10.38 | -9.8 | -7.54 | -5.01 | |
| Issuance of Common Stock | 10.78 | 6.62 | 8.16 | 3.7 | 14.8 | |
| Other Financing Activities | -0.15 | - | - | - | - | |
| Financing Cash Flow | 10.64 | 6.62 | 8.16 | 3.7 | 14.8 | |
| Net Cash Flow | 3.85 | -3.77 | -1.64 | -3.85 | 9.78 | |
| Levered Free Cash Flow | -4.29 | -5.11 | -4.33 | -3.01 | -0.21 | |
| Unlevered Free Cash Flow | -4.29 | -5.11 | -4.33 | -3.01 | -0.21 | |
| Change in Working Capital | -0.39 | 0.28 | 1.01 | 1.25 | 0.14 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.